New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has notified the revised ceiling prices of several essential medicines under the Drugs (Prices Control) Order, 2013 (DPCO), impacting formulations such as Riboflavin 10 mg tablets, Peritoneal dialysis solutions, Ethyl alcohol (Denatured 70%), and Human Normal Immunoglobulin injections.

According to the NPPA notification, the ceiling price for Riboflavin 10 mg tablets has been fixed at Rs 1.11 per tablet (exclusive of GST), based on market data as of October 2023. The formulation is marketed by Shreya Life Sciences Pvt Ltd.

For Peritoneal dialysis solutions, widely used in renal replacement therapy, the NPPA has capped the ceiling price at Rs 0.22 per ml, bringing down costs significantly. Major brands impacted include Baxte

See Full Page